Director of Clinical Operations, Clinical Development
Gloria Morgan oversees all clinical operations within the Phase 1 Unit, including supervision of Clinical Trials Unit staff, managing proposal preparation, providing input into clinical trial design, managing vendor and collaborator relationships, and ensuring operations comply with FDA, NIH, CLIA, GCP, and JCAHO regulations.
Prior to joining SRI in 2014, Morgan was a business development manager at the Michigan Institute for Clinical and Health Research. Earlier, she was a project manager and clinical research coordinator at Lotus Clinical Research, where she facilitated the planning, execution, and regulatory documentation for Phase 1-3 clinical research studies in such areas as post-operative pain and opioid-induced constipation. During her graduate studies, Chou was a clinical research coordinator for peripheral arterial disease and Alzheimer’s disease studies at the University of Michigan.
Morgan received a B.S. degree in biopsychology and cognitive science from the University of Michigan. Her M.S. degree in clinical research administration is from Eastern Michigan University. She is a certified Project Management Professional, a certified phlebotomy technician, and holds a Lean Healthcare certification.
